Hypovolemia

Hypovolemia is a generic term covering two related but distinct processes: volume depletion, the loss of sodium-containing fluid from the intravascular and interstitial (extracellular) spaces, which is more closely linked to hypotension and tachycardia; and dehydration, the loss of water from both the extracellular and intracellular spaces (for example, from excess sweating or reduced water intake), which raises plasma sodium and osmolality and may or may not cause hypotension or tachycardia. In practice the two overlap and are usually assessed and managed together under one clinical umbrella. Causes span hemorrhage; gastrointestinal, renal, skin, or respiratory fluid losses; third-space (intravascular) sequestration; and simple poor oral intake. Fluid prescribing deserves the same discipline as drug prescribing — the choice of fluid, its rate, and its volume are all part of the prescription, not an afterthought.^[1]

This chapter covers the adult approach: recognizing and grading severity, distinguishing straightforward volume depletion from hemodynamically unstable hypovolemic shock, matching fluid type and rate to cause and severity, and the pharmacist-relevant medication causes of hypovolemia and the sick-day medication-hold guidance that prevents and treats them. For the pediatric approach — a different weight-based framework with its own severity scale — see Dehydration in Children.

How hypovolemia presents

Symptoms include thirst, fatigue, muscle weakness, palpitations, and postural lightheadedness. History should identify an external source of loss — bleeding, vomiting, diarrhea, excessive diuresis, or excessive perspiration — and should include a focused medication review, since several common drug classes contribute to volume depletion (see Risk Factors). Presentation in older adults is frequently nonspecific — confusion, falls, or generalized weakness rather than classic thirst — so maintain a lower threshold to assess volume status in this group.^[2]

Physical examination findings

An increase in heart rate of more than 30 beats per minute after 1 minute of standing from a recumbent position is the most accurate single sign of moderate-to-severe volume depletion — but beta-blocker use blunts this response, so its absence does not rule out significant volume depletion in a patient taking one.^[2]

A postural decline in systolic blood pressure of more than 20 mmHg suggests volume depletion; persistently low blood pressure even while supine indicates moderate-to-severe volume loss.

Dry axillae support the diagnosis; moist mucous membranes and axillae argue against it. Decreased skin turgor, prolonged capillary refill, and decreased eyeball tension are late signs that are comparatively insensitive in adults — in contrast to children, where these signs are more reliable (see Dehydration in Children) — and should not be relied on alone.

• Hemorrhage — traumatic, surgical, gastrointestinal, obstetric, or otherwise.
• Gastrointestinal losses — vomiting, diarrhea, nasogastric suction, or high-output stoma/fistula drainage.
• Renal losses — osmotic diuresis (for example, from hyperglycemia), diabetes insipidus, salt-wasting nephropathy, adrenal insufficiency, or over-diuresis from diuretic therapy.
• Skin and respiratory losses — excessive sweating, fever, burns, or high ambient temperature with inadequate fluid replacement.
• Third-space (fluid sequestration) losses — pancreatitis, bowel obstruction, sepsis, major surgery, or significant hypoalbuminemia, where intravascular volume is lost into a non-functional space without any external fluid loss.
• Poor oral intake — reduced access to fluids, impaired thirst sensation, dysphagia, nausea, depression, or cognitive or mobility impairment, especially in older adults.
• Older age — blunted thirst sensation, reduced renal concentrating ability, and a higher prevalence of contributing medications and comorbidities.
• Medications that reduce intake, increase losses, or blunt the compensatory response to volume loss (see the table below).

Drugs that can alter hydration status or contribute to hypovolemia

A focused medication review is one of the highest-yield steps a pharmacist can take in a patient with unexplained or recurrent volume depletion.^[2]

History

• Characterize the source of loss — bleeding, vomiting, diarrhea, excessive diuresis, or excessive perspiration — and its duration and severity.
• Ask specifically about thirst, fatigue, muscle weakness, palpitations, and postural lightheadedness.
• Take a complete medication history, including nonprescription and natural health products, looking specifically for the drug classes listed in Risk Factors.
• Recognize that presentation in older adults is often nonspecific — confusion, falls, or generalized weakness rather than classic symptoms.

Physical examination

Determine the presence and severity of volume depletion and rule out hemorrhage as the cause. See Recognize the Condition for the specific findings — orthostatic heart rate and blood pressure changes, axillae, skin turgor, capillary refill — and their relative reliability in adults.

Laboratory testing

• Blood: hematocrit and albumin concentrations rise with hypovolemia, and urea rises disproportionately to creatinine. Serum sodium may be normal, low, or high, depending on the type and amount of fluid the patient has been able to consume in response to thirst.
• Urine: hypovolemia is suggested by a urine volume under 0.5 mL/kg/h, a urine sodium under 20 mmol/L, or a urine osmolality over 450 mOsm/kg. Urine specific gravity is a less accurate marker, but a value over 1.020 suggests concentrated urine and may indicate hypovolemia.

When the diagnosis is uncertain

When hypovolemia is suspected but not certain — for example, unexplained hypotension or tachycardia without an obvious history of fluid loss — a brief intravenous fluid challenge can serve as both a diagnostic test and the first step of treatment; see Choose Initial Treatment.

• Restore intravascular and extracellular volume to relieve symptoms and prevent end-organ injury.
• Identify and treat the underlying cause of volume loss — the cause determines both the fluid choice and the required rate.
• Match fluid type, rate, and route to the severity of hypovolemia and the specific losses being replaced.
• Correct or prevent associated electrolyte and acid-base disturbances without overcorrecting them.
• Avoid iatrogenic fluid overload, particularly in heart failure, significant renal impairment, and older adults.
• Identify and address medication causes of volume depletion, with a clear plan for holding and safely restarting them.
• Transition to oral intake and maintenance fluids as soon as it is safe to do so.

• Use correct oral rehydration technique — small, frequent volumes rather than a large volume at once — for any patient managed with oral therapy.
• Identify and treat the underlying cause directly wherever possible — for example, antiemetic therapy for vomiting, or addressing a source of excessive perspiration or fever — since fluid replacement alone does not fix an ongoing cause.
• Reassess and adjust or discontinue implicated medications (see Risk Factors and Choose Initial Treatment) as part of the treatment plan, not only as an afterthought once fluids have been given.
• Counsel on fall precautions in a patient with orthostatic symptoms until volume status has normalized, particularly in older adults.
• Weigh the patient before and after rehydration when practical — each kilogram of weight change corresponds closely to a litre of fluid, and this is a useful objective check that the estimated deficit was actually replaced.
• Educate the patient and caregivers on the specific signs that should prompt a return to care — see Red Flags and Refer.
• For a patient being sent home with sick-day medication-hold instructions, confirm they (or a caregiver) understand which medications to hold, for how long, and the specific signs that mean they should seek care rather than continue self-managing.

Pregnancy

Physiologic plasma volume expansion in pregnancy changes baseline vital signs, so standard adult hypotension/tachycardia thresholds should be interpreted with this in mind. Hemorrhage — for example, postpartum hemorrhage or ectopic pregnancy — is an important and time-critical cause of hypovolemia in pregnancy; manage with the same urgency as in a non-pregnant patient, with combined obstetric involvement. Isotonic crystalloid is the standard initial fluid; involve obstetric and, where relevant, anesthesia or critical care specialists early for significant hypovolemia in pregnancy.

Breastfeeding

Standard isotonic crystalloids (0.9% sodium chloride, lactated Ringer's) are compatible with breastfeeding and do not require any interruption.

Pediatrics

Not covered in this chapter — dehydration and hypovolemia in children are assessed and dosed differently, with a weight-based deficit/maintenance calculation and different severity thresholds; see Dehydration in Children.

Older adults

Thirst sensation and the compensatory tachycardic response to volume loss are both blunted with age (and further blunted by beta-blocker therapy), and presentation is frequently nonspecific — confusion, falls, or generalized weakness rather than classic symptoms — so maintain a lower threshold to assess volume status. Older adults are also more susceptible to fluid overload with standard resuscitation volumes; use smaller boluses with more frequent reassessment, and review the full medication list for contributing causes (see Risk Factors), since polypharmacy is common in this group.

Heart failure

Standard resuscitation volumes can precipitate acute decompensation. When intravenous fluid is genuinely needed, use smaller boluses (for example, 250 mL rather than a full litre), reassess frequently for signs of volume overload between boluses, and involve a specialist early for anything beyond straightforward, mild volume depletion.

Renal impairment

Avoid or use lactated Ringer's cautiously in significant renal impairment or pre-existing hyperkalemia given its potassium and lactate content; 0.9% sodium chloride avoids this specific concern but carries its own hyperchloremic-acidosis risk with large volumes. Diuretics, ACE inhibitors/ARBs, and SGLT2 inhibitors all warrant the same sick-day hold guidance in this population, often at a lower threshold given the added baseline renal risk.^[12]

Reassess heart rate, blood pressure (including postural change), peripheral perfusion, jugular venous pressure, mental status, and urine output at intervals appropriate to severity — after every bolus in significant hypovolemia, and periodically during ongoing oral or maintenance therapy. Recheck electrolytes, renal function, and acid-base status when initial derangement, ongoing losses, or large-volume resuscitation warrant it, and again after any RAAS-inhibitor or diuretic interruption before restarting it. Watch specifically for signs of fluid overload — new or worsening peripheral edema, rising jugular venous pressure, crackles on lung auscultation, or worsening oxygenation — especially in heart failure, significant renal impairment, and older adults, where the margin between under- and over-resuscitation is narrower. Weigh the patient periodically when practical as an objective check on fluid balance. Once volume status has normalized, confirm the sick-day medication list has actually been restarted — an interrupted ACE inhibitor, ARB, or SGLT2 inhibitor left off by default loses its long-term cardiovascular and renal benefit.

1. Confirm the fluid type, rate, and route actually match the assessed severity and cause — under-dosing (too slow, too little) is a common reason for apparent treatment failure.
2. Reassess for an unidentified or ongoing source of loss — occult or ongoing hemorrhage, unrecognized third-spacing, or continuing GI/renal losses outpacing replacement.
3. If hemodynamics remain abnormal despite an adequate initial fluid challenge or bolus, repeat the bolus and reassess rather than simply continuing a slow maintenance-rate infusion.
4. If large-volume 0.9% sodium chloride has produced a rising chloride or a widening metabolic acidosis, switch to a balanced crystalloid for ongoing resuscitation.
5. If hypotension persists despite what appears to be adequate volume replacement, reconsider the diagnosis — a concurrent cardiogenic, obstructive, or distributive (for example, septic or anaphylactic) component to the shock state may need its own specific treatment in addition to fluids, and escalation to critical care may be needed.
6. Confirm any implicated medication was actually held, and reassess the full medication list again if volume status is not improving as expected.

• Using dextrose 5% in water (D5W) to treat acute hypotension or shock — it is a poor plasma volume expander and does not correct intravascular volume depletion.
• Defaulting to large-volume 0.9% sodium chloride for critically ill or larger-volume resuscitation instead of a balanced crystalloid, risking hyperchloremic metabolic acidosis.^[4]
• Treating hemorrhagic hypovolemia with crystalloid alone instead of escalating early to balanced blood-product transfusion and urgent control of the bleeding source.
• Missing a medication cause of hypovolemia — over-diuresis, an SGLT2 inhibitor, or an ACE inhibitor/ARB — and treating only the fluid deficit without addressing the cause.
• Leaving a RAAS inhibitor or SGLT2 inhibitor discontinued indefinitely after a sick-day hold instead of restarting it once the illness has resolved.
• Over-aggressive fluid resuscitation in heart failure, significant renal impairment, or an older adult, precipitating fluid overload.
• Reaching for a colloid, especially a starch compound, as a routine first-line resuscitation fluid instead of crystalloid.
• Not replacing potassium losses associated with diarrhea, vomiting, or over-diuresis once fluid resuscitation is underway.
• Confusing volume depletion (sodium-containing extracellular fluid loss) with dehydration (free-water loss) and choosing a fluid that does not match the actual deficit.
• Relying on skin turgor or capillary refill alone to rule out hypovolemia in an adult — both are late, insensitive signs in this age group.
• Under-recognizing hypovolemia in an older adult who presents atypically (confusion, falls, generalized weakness) rather than with classic thirst and postural symptoms.

How to use this table: Doses are typical adult doses and require patient-specific confirmation, especially in heart failure, significant renal impairment, or older age. Select any drug name to open its complete Pharmasist Drug Database page.

Blood products

Preferred first-line fluid for active hemorrhage; use in a balanced ratio rather than a red-cell-predominant or crystalloid-predominant approach.

Crystalloids

Colloids

Not recommended as a primary resuscitation fluid in current practice - see Choose Initial Treatment.

Hemostatic adjunct (hemorrhagic hypovolemia)

Estimating fluid deficit and maintenance needs

Severity is expressed as a percentage of body weight, assuming each litre of fluid lost weighs 1 kg: multiply the estimated percentage deficit (see Recognize the Condition) by the current body weight in kilograms to estimate the deficit in litres. Maintenance fluid is given in addition to deficit replacement: approximately 30 mL/kg/day, or 2000-2500 mL/day, containing approximately 75 mmol of sodium and 50 mmol of potassium over 24 hours.

For burns, the Parkland formula estimates the first 24-hour crystalloid requirement as 4 mL/kg per % total body surface area burned, with half given in the first 8 hours from the time of injury and the remainder over the following 16 hours; lactated Ringer's is the standard initial fluid.

Evidence note: balanced-crystalloid preference, hydroxyethyl starch avoidance, and massive-transfusion/tranexamic-acid dosing reflect current international critical-care and trauma evidence, cross-checked against the 2026 Surviving Sepsis Campaign guideline.^[3]